JPY4,525.00
1.50% today
Tokyo, Apr 03, 08:14 am CET
ISIN
JP3463000004
Symbol
4502
Index
Sector
Industry

Takeda Pharmaceutical Stock price

JPY4,540.00
+139.00 3.16% 1M
+340.00 8.10% 6M
+359.00 8.59% YTD
+436.00 10.62% 1Y
+947.00 26.36% 3Y
+1,372.00 43.31% 5Y
-1,393.00 23.48% 10Y
Tokyo, Closing price Thu, Apr 03 2025
+82.00 1.84%
ISIN
JP3463000004
Symbol
4502
Index
Sector
Industry

Key metrics

Market capitalization JPY7.07t
Enterprise Value JPY11.41t
P/E (TTM) P/E ratio 33.79
EV/FCF (TTM) EV/FCF 13.48
EV/Sales (TTM) EV/Sales 2.49
P/S ratio (TTM) P/S ratio 1.54
P/B ratio (TTM) P/B ratio 0.95
Dividend yield 4.40%
Last dividend (FY25) JPY196.00
Revenue growth (TTM) Revenue growth 9.83%
Revenue (TTM) Revenue JPY4.58t
EBIT (operating result TTM) EBIT JPY620.18b
Free Cash Flow (TTM) Free Cash Flow JPY846.78b
Cash position JPY494.13b
EPS (TTM) EPS JPY131.93
P/E forward 49.75
P/S forward 1.53
EV/Sales forward 2.48
Show more

Is Takeda Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Takeda Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Takeda Pharmaceutical forecast:

10x Buy
59%
7x Hold
41%

Analyst Opinions

17 Analysts have issued a Takeda Pharmaceutical forecast:

Buy
59%
Hold
41%

Financial data from Takeda Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
4,579,021 4,579,021
10% 10%
100%
- Direct Costs 2,154,627 2,154,627
8% 8%
47%
2,424,394 2,424,394
11% 11%
53%
- Selling and Administrative Expenses 335,763 335,763
27% 27%
7%
- Research and Development Expense 710,076 710,076
2% 2%
16%
1,378,555 1,378,555
13% 13%
30%
- Depreciation and Amortization 758,371 758,371
0% 0%
17%
EBIT (Operating Income) EBIT 620,184 620,184
35% 35%
14%
Net Profit 208,065 208,065
17% 17%
5%

In millions JPY.

Don't miss a Thing! We will send you all news about Takeda Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Takeda Pharmaceutical Stock News

AD HOC NEWS
2 months ago
Takeda Pharmaceutical Company Limited / JP3463000004
AD HOC NEWS
5 months ago
Takeda Pharmaceutical Company Limited / JP3463000004

Company Profile

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Head office Japan
CEO Christophe Weber
Employees 49,281
Founded 1781
Website www.takeda.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today